Stock 7444 HARIMA-KYOWA CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Harima-Kyowa Co.,LTD.

Equities

7444

JP3772800003

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 01:51:13 2024-05-02 am EDT 		5-day change 1st Jan Change
2,199 JPY +3.05% Intraday chart for Harima-Kyowa Co.,LTD. +2.95% -3.72%
2023 Harima-Kyowa Co.,LTD. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
2016 Nishimatsuya Chain Co., Ltd. acquired 1.42% stake in Harima-Kyowa Co. Ltd. from Tsuda Bussan Co., Ltd. CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 12,662 9,067 7,164 9,373 8,846 8,792
Enterprise Value (EV) 1 11,904 7,405 4,936 6,449 6,201 4,802
P/E ratio 9.41 x 7.57 x 5.99 x 8.07 x 7.36 x 6.32 x
Yield 1.57% 2.25% 2.85% 2.24% 2.43% 2.51%
Capitalization / Revenue 0.27 x 0.19 x 0.14 x 0.17 x 0.15 x 0.15 x
EV / Revenue 0.25 x 0.15 x 0.1 x 0.12 x 0.11 x 0.08 x
EV / EBITDA 5.13 x 3.42 x 2.28 x 2.99 x 2.77 x 2.02 x
EV / FCF -17.7 x 8.96 x 5.92 x 6.74 x -19.2 x 3.63 x
FCF Yield -5.66% 11.2% 16.9% 14.8% -5.2% 27.5%
Price to Book 0.76 x 0.52 x 0.39 x 0.47 x 0.42 x 0.4 x
Nbr of stocks (in thousands) 5,372 5,374 5,374 5,374 5,374 5,374
Reference price 2 2,357 1,687 1,333 1,744 1,646 1,636
Announcement Date 6/29/18 6/28/19 6/29/20 6/30/21 6/30/22 6/30/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 46,967 48,230 51,829 54,477 57,781 60,156
EBITDA 1 2,320 2,167 2,163 2,158 2,238 2,383
EBIT 1 1,801 1,609 1,591 1,558 1,656 1,778
Operating Margin 3.83% 3.34% 3.07% 2.86% 2.87% 2.96%
Earnings before Tax (EBT) 1 1,940 1,752 1,755 1,725 1,772 2,012
Net income 1 1,345 1,198 1,196 1,162 1,202 1,391
Net margin 2.86% 2.48% 2.31% 2.13% 2.08% 2.31%
EPS 2 250.4 222.9 222.5 216.2 223.7 258.8
Free Cash Flow 1 -673.5 826.8 833.8 956.1 -322.6 1,321
FCF margin -1.43% 1.71% 1.61% 1.76% -0.56% 2.2%
FCF Conversion (EBITDA) - 38.15% 38.55% 44.31% - 55.44%
FCF Conversion (Net income) - 69.01% 69.71% 82.28% - 94.99%
Dividend per Share 2 37.00 38.00 38.00 39.00 40.00 41.00
Announcement Date 6/29/18 6/28/19 6/29/20 6/30/21 6/30/22 6/30/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 26,780 27,819 29,244 14,143 15,702 30,776 14,920 15,962 31,645 15,124
EBITDA - - - - - - - - - -
EBIT 1 1,007 906 838 200 478 939 435 456 924 435
Operating Margin 3.76% 3.26% 2.87% 1.41% 3.04% 3.05% 2.92% 2.86% 2.92% 2.88%
Earnings before Tax (EBT) 1 1,097 1,040 872 244 544 1,115 470 524 1,078 465
Net income 1 729 695 567 166 345 745 326 329 713 320
Net margin 2.72% 2.5% 1.94% 1.17% 2.2% 2.42% 2.18% 2.06% 2.25% 2.12%
EPS 2 135.8 129.4 105.6 30.98 64.30 138.6 60.66 61.38 132.8 59.56
Dividend per Share - - - - - - - - - -
Announcement Date 11/8/19 11/10/20 11/10/21 2/10/22 8/10/22 11/10/22 2/10/23 8/10/23 11/13/23 2/9/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 758 1,662 2,228 2,924 2,645 3,990
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -674 827 834 956 -323 1,321
ROE (net income / shareholders' equity) 8.36% 7.02% 6.7% 6.08% 5.86% 6.45%
ROA (Net income/ Total Assets) 4.66% 4.08% 3.88% 3.55% 3.54% 3.62%
Assets 1 28,848 29,376 30,837 32,754 33,996 38,469
Book Value Per Share 2 3,106 3,253 3,411 3,743 3,905 4,130
Cash Flow per Share 2 311.0 468.0 485.0 598.0 559.0 778.0
Capex 1 911 309 903 167 838 365
Capex / Sales 1.94% 0.64% 1.74% 0.31% 1.45% 0.61%
Announcement Date 6/29/18 6/28/19 6/29/20 6/30/21 6/30/22 6/30/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
HARIMA-KYOWA CO.,LTD. Stock Harima-Kyowa Co.,LTD.
-3.72% 77.29M
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-1.88% 24.09B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.11% 8.2B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.55% 7.97B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-4.06% 7.84B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+2.26% 4.66B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.32B
EBOS GROUP LIMITED Stock EBOS Group Limited
+1.41% 4.19B
GALENICA AG Stock Galenica AG
-3.02% 3.89B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+21.42% 3.62B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 7444 Stock
  4. Financials Harima-Kyowa Co.,LTD.